Which assessment data for a pediatric client supports the diagnosis of familial or idiopathic central diabetes insipidus (DI)? Select all that apply
1. Polyuria
2. Polydipsia
3. Nocturia
4. Enuresis
5. Constipation
3, 4, 5
Explanation:
1. Polyuria is not a clinical manifestation associated with familial or idiopathic central DI.
2. Polydipsia is not a clinical manifestation associated with familial or idiopathic central DI.
3. Nocturia is a clinical manifestation associated with familial or idiopathic central DI.
4. Enuresis a clinical manifestation associated with familial or idiopathic central DI.
5. Constipation a clinical manifestation associated with familial or idiopathic central DI.
You might also like to view...
A 49-year-old patient is in the clinic for a
follow-up visit 6 months after starting a beta blocker for treatment of hypertension. During this visit, his blood pressure is 169/98 mm Hg, and he eventually confesses that he stopped taking this medicine 2 months ago because of an "embarrassing problem." What problem did the patient most likely experience with this medication that caused him to stop taking it? a. Urge incontinence b. Dizziness when standing up c. Excessive flatus d. Impotence
A patient with hemophilia is admitted with acute bleeding. Until the cause of the bleeding is determined, the nurse should be prepared to perform which intervention?
1. infusing packed red blood cells 2. infusing normal saline 3. infusing heparin 4. infusing fresh-frozen plasma
Parents bring a child to the clinic and report a "rash" on her knee. On assessment, the APRN notes the area to be a reddish-pink lesion covered with silvery scales. What would the APRN chart?
A) Seborrhea B) Contact dermatitis C) Eczema D) Psoriasis
Studies are currently underway to determine mortality risk of ziprasidone. Findings indicate that ziprasidone has additional mortality risk related to which of the following?
a. slightly prolonging the cardiac QT interval, increasing susceptibility to arrhythmias b. exacerbation of the sleep apnea commonly observed with long-term use of these drugs c. lack of improvement in "negative" symptoms, even after long-term use of these drugs d. development of diabetes that sometimes accompanies long-term use of these drugs